Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07811362 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CRPS-RISE Outcomes Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Start date pushed from Sep 16, 2026 to Sep 17, 2026
    • Study sites: 0 to 1
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to learn about how well neridronate keeps working in the months after treatment. For 12 or up to 24 months while the registry is open participants will answer online survey questions about their CRPS pain, medication use or procedures done and how CRPS affects what they are able to do.
Trial Details
NCT Number NCT07811362
Lead Sponsor Ambros Therapeutics, Inc.
Conditions
(from sponsor)		 Complex Regional Pain Syndrome I (CRPS I)
Related terms Complex Regional Pain Syndromes, Reflex Sympathetic Dystrophy
Enrollment 270 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov